127 related articles for article (PubMed ID: 34550926)
1. The Incidence of Occult Malignant and High-Risk Pathologic Findings in Breast Reduction Specimens.
Razavi SA; Hart AM; Betarbet U; Li X; Carlson GW; Losken A
Plast Reconstr Surg; 2021 Oct; 148(4):534e-539e. PubMed ID: 34550926
[TBL] [Abstract][Full Text] [Related]
2. Proliferative Lesions Found at Reduction Mammaplasty: Incidence and Implications in 995 Breast Reductions.
Mastroianni M; Lin A; Hughes K; Colwell AS
Plast Reconstr Surg; 2019 Feb; 143(2):271e-275e. PubMed ID: 30489497
[TBL] [Abstract][Full Text] [Related]
3. A Risk-Stratified Comparison of High-Risk Findings in Reduction Mammoplasty.
Dreifuss SE; Landfair AS; De La Cruz C
Ann Plast Surg; 2018 Jul; 81(1):36-38. PubMed ID: 29762441
[TBL] [Abstract][Full Text] [Related]
4. Reduction mammaplasty in patients with history of breast cancer: The incidence of occult cancer and high-risk lesions.
Merkkola-von Schantz PA; Jahkola TA; Krogerus LA; Kauhanen SMC
Breast; 2017 Oct; 35():157-161. PubMed ID: 28753473
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Incidentally Found Proliferative Lesions in Oncoplastic and Macromastia Breast Reductions.
Morrison KA; Choi M; Karp NS
Plast Reconstr Surg; 2023 Oct; 152(4):559e-565e. PubMed ID: 36862961
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Retrospective Analysis of Complications After Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia: Are These Procedures Equally Safe?
Imahiyerobo TA; Pharmer LA; Swistel AJ; Talmor M
Ann Plast Surg; 2015 Oct; 75(4):370-5. PubMed ID: 24691307
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for Pathologic Evaluation of Reduction Mammoplasty Specimens: A Prospective Study With Systematic Tissue Sampling.
Ambaye AB; Goodwin AJ; MacLennan SE; Naud S; Weaver DL
Arch Pathol Lab Med; 2017 Nov; 141(11):1523-1528. PubMed ID: 28795842
[TBL] [Abstract][Full Text] [Related]
8. Incidental Pathologic Findings in Young Adult Reduction Mammaplasty.
Maroney J; Collins KC; Dannheim K; Staffa SJ; Saldanha FYL; Labow BI; Rogers-Vizena CR
Plast Reconstr Surg; 2021 Mar; 147(3):391-400. PubMed ID: 33620923
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study.
Ambaye AB; MacLennan SE; Goodwin AJ; Suppan T; Naud S; Weaver DL
Plast Reconstr Surg; 2009 Nov; 124(5):1386-1392. PubMed ID: 20009822
[TBL] [Abstract][Full Text] [Related]
10. Comparing Outcomes after Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia.
Marano AA; Grover K; Peysakhovich A; Lin AJ; Castillo W; Rohde CH
Plast Reconstr Surg; 2022 Mar; 149(3):541-548. PubMed ID: 35006098
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic mastectomy: pathologic findings in high-risk patients.
Khurana KK; Loosmann A; Numann PJ; Khan SA
Arch Pathol Lab Med; 2000 Mar; 124(3):378-81. PubMed ID: 10705389
[TBL] [Abstract][Full Text] [Related]
12. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
13. Pathology Evaluation of Reduction Mammaplasty Specimens and Subsequent Diagnosis of Malignant Breast Disease: A Claims-Based Analysis.
Sears ED; Lu YT; Chung TT; Momoh AO; Chung KC
World J Surg; 2019 Jun; 43(6):1546-1553. PubMed ID: 30719555
[TBL] [Abstract][Full Text] [Related]
14. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience.
Colwell AS; Kukreja J; Breuing KH; Lester S; Orgill DP
Plast Reconstr Surg; 2004 Jun; 113(7):1984-8. PubMed ID: 15253187
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic findings in breast reduction specimens.
Kececi Y; Tasli FA; Yagcı A; Sır E; Canpolat S; Vardar E
J Plast Surg Hand Surg; 2014 Apr; 48(2):122-5. PubMed ID: 23879776
[TBL] [Abstract][Full Text] [Related]
16. Incidental breast carcinoma in reduction mammoplasty.
Huysmans M; Bronckaers M; Schillebeeckx C; Servaes D
Acta Chir Belg; 2017 Oct; 117(5):308-311. PubMed ID: 28610472
[TBL] [Abstract][Full Text] [Related]
17. A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery.
Jackson KM; Millen JC; Orozco JIJ; Stern SL; Fancher CE; Grumley JG
Ann Surg Oncol; 2023 Oct; 30(10):6159-6166. PubMed ID: 37535266
[TBL] [Abstract][Full Text] [Related]
18. Is macromastia a risk factor for breast cancer? A study on 198 patients.
Talghini S
Pak J Biol Sci; 2013 Nov; 16(21):1348-52. PubMed ID: 24511745
[TBL] [Abstract][Full Text] [Related]
19. Should we be analysing breast reduction specimens? A systematic analysis of over 1,000 consecutive cases.
Hassan FE; Pacifico MD
Aesthetic Plast Surg; 2012 Oct; 36(5):1105-13. PubMed ID: 22678135
[TBL] [Abstract][Full Text] [Related]
20. Reduction mammoplasty is beneficial in women with and without history of breast cancer.
Desouki MM
Womens Health (Lond); 2015 Jul; 11(4):419-22. PubMed ID: 26245153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
